A Phase I, Open-label, Dose-escalation Study of the safety and Pharmacokinetics of BLYG8824A Administered Intravenously as A Single Agent in patients with Locally Advanced or Metastatic Colorectal Cancer

  • Markman, Ben (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusActive
Effective start/end date8/09/23 → 8/09/25

Keywords

  • clinical trial
  • metastatic cancer
  • Colorectal cancer
  • colon cancer